OTC & Nutraceuticals US

US Ready-to-Use Therapeutic Food Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

US Ready-to-Use Therapeutic Food Market Industry Trends and Forecast to 2034: Segmented by (Product, Buyer, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $398.8 Mn Placeholder estimate
Estimate 2025 $414.8 Mn 46.1% of the global market
Projected 2034 $590.4 Mn 42.3% Adds $175.6 Mn over 9 forecast years
CAGR 2025–2034 4.0% Faster than 20% of 84 OTC & Nutraceuticals markets here
Key players 5 Companies profiled
  • US is 46.15% of the global market.
  • In North America, the largest is US (this report) at $414.8 Mn.
  • Fastest growing: Canada at 6% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$175.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Ready-to-Use Therapeutic Food Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $398.8 Mn — —
2025 (base) $414.8 Mn +$16.0 Mn —
2026 (forecast) $431.4 Mn +$16.6 Mn +4%
2027 (forecast) $448.6 Mn +$17.3 Mn +8.2%
2028 (forecast) $466.6 Mn +$17.9 Mn +12.5%
2029 (forecast) $485.2 Mn +$18.7 Mn +17%
2030 (forecast) $504.7 Mn +$19.4 Mn +21.7%
2031 (forecast) $524.8 Mn +$20.2 Mn +26.5%
2032 (forecast) $545.8 Mn +$21.0 Mn +31.6%
2033 (forecast) $567.7 Mn +$21.8 Mn +36.9%
2034 (forecast) $590.4 Mn +$22.7 Mn +42.3%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Ready-to-Use Therapeutic Food Market Analysis at a glance
Market size, 2025$414.8 Mn placeholder estimate
Forecast, 2034$590.4 Mn placeholder estimate
Growth (CAGR), 2025–20344.0% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct and buyer (see all)
Key playersNutriset, Edesia Nutrition, Valid Nutrition, Mana Nutrition, InnoFaso (see all)
Regulator in the USFDASource: US Food and Drug Administration. Checked 14 Nov 2026.Source: US Food and Drug Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Ready-to-Use Therapeutic Food Market Analysis Executive Summary

Ready-to-use therapeutic food is a nutrient-rich paste that treats severe child malnutrition at home.

Key segments of the ready-to-Use Therapeutic Food market include product (RUTF, RUSF and Micronutrient Powders) and buyer (UNICEF, Governments and NGOs).

Bar chart: US Ready-to-Use Therapeutic Food market size, 2024–2034, placeholder estimates. $398.8 Mn in 2024, $414.8 Mn in 2025 and $590.4 Mn in 2034, 4.0% CAGR.
US Ready-to-Use Therapeutic Food market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Ready-to-Use Therapeutic Food Market Dynamics

Market Growth Drivers

Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the ready-to-Use Therapeutic Food market.

Opportunity

Digital tools for community health, local manufacturing and public-private partnerships give the ready-to-Use Therapeutic Food market room to grow.

Market Restraints

Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the ready-to-Use Therapeutic Food market.

Competitive Landscape for Ready-to-Use Therapeutic Food Market in the US

The ready-to-Use Therapeutic Food market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Ready-to-Use Therapeutic Food Market in the US

Ready-to-Use Therapeutic Food in the US: rules and health figures

New drugs need approval from the US Food and Drug Administration (FDA); many over-the-counter medicines are sold under FDA monographs instead.⁠[1] Dietary supplements do not need FDA approval before sale; under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA acts against unsafe or mislabelled products.⁠[2] Stunting in children under 5: 3.8% of children under 5 in 2022, the latest World Bank figure for the US.⁠[3]

[1] US Food and Drug Administration. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] World Bank Open Data, Stunting in children under 5 (% of children under 5). Retrieved 22 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern ready-to-Use Therapeutic Food products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in the US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Ready-to-Use Therapeutic Food right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 22 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Ready-to-Use Therapeutic Food in context

The US compared

  • Stunting in children under 5: 3.8% of children under 5 (2022).[1]
  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[2]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[3]

[1] World Bank Open Data, Stunting in children under 5 (% of children under 5). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 22 Nov 2026.

Free data on this topic

Inside the US

Quick answers

Frequently asked questions

How big is the Ready-to-Use Therapeutic Food market in the US?
Placeholder estimate: about $414.8 Mn in 2025, rising to about $590.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Ready-to-Use Therapeutic Food market in the US growing?
Placeholder estimate: about 4.0% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Ready-to-Use Therapeutic Food market report cover?
The report splits the market by product (RUTF, RUSF, Micronutrient Powders) and buyer (UNICEF, Governments, NGOs).
Who are the key players in the Ready-to-Use Therapeutic Food market?
Key players include Nutriset, Edesia Nutrition, Valid Nutrition, Mana Nutrition and InnoFaso.
What is driving the Ready-to-Use Therapeutic Food market?
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the ready-to-Use Therapeutic Food market.
Who regulates Ready-to-Use Therapeutic Food in the US?
New drugs need approval from the US Food and Drug Administration (FDA); many over-the-counter medicines are sold under FDA monographs instead. Dietary supplements do not need FDA approval before sale; under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the FDA acts against unsafe or mislabelled products. Source: US Food and Drug Administration. Checked 14 Nov 2026. Source: US Food and Drug Administration. Checked 14 Nov 2026.
What does World Bank report for the US?
Stunting in children under 5: 3.8% of children under 5 in 2022, the latest World Bank figure. Source: World Bank Open Data, Stunting in children under 5 (% of children under 5). Retrieved 22 Nov 2026.
How many people in the US are 65 or older?
18.4% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 22 Nov 2026.
How much research is published on Ready-to-Use Therapeutic Food?
PubMed lists 112 papers on Ready-to-Use Therapeutic Food added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in US

See all

Related on nutrition and pediatric

See the topic